Logo for SIGA Technologies Inc

SIGA Investor Relations Material

Latest events

Logo for SIGA Technologies Inc

Q3 2024

SIGA
Logo for SIGA

Q3 2024

7 Nov, 2024
Logo for SIGA

Q2 2024

1 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from SIGA Technologies Inc

Access all reports
Segment Data
Access more data
Revenue by
Geography
U.S.
Canada
EMEA
APAC
Other
Expenses by
Financials
SIGA Technologies, Inc. is a pharmaceutical company focused on the development and commercialization of countermeasures to address infectious diseases and biological threats. The company specializes in antiviral therapies, with a particular emphasis on treatments for diseases caused by orthopoxviruses, including smallpox. SIGA’s products are primarily used by government agencies and health organizations to strengthen preparedness for potential outbreaks or bioterrorism events. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.